A mix of agile mid-size players and innovative small caps are grabbing market share and growing revenue at breakneck speed.

Training Claude on copyrighted books it purchased was fair use, but piracy wasn't, the judge ruled.

Phathom gains FDA exclusivity for VOQUEZNA through 2032, boosting stock. DCF values shares at $14 with 43% upside potential.

In a market increasingly dominated by algorithms and machine learning, understanding AI-driven trading systems isn’t enough.

The Global Magazine of News and Ideas. This black-and-white photo shows students and faculty milling about near the front entrance of a large building fronted with limestone columns and a wide ...

Plus: Cerris Builders completes industrial build in Grapevine, European architecture studio Räkkhaus plants Dallas roots, and more updates.